The CatBoost model outperformed other machine learning methods in predicting early hyperkalemia risk in patients with chronic kidney disease, demonstrating high classification accuracy.
Does the CatBoost machine learning model accurately predict the risk of early hyperkalemia in patients with chronic kidney disease?
The CatBoost machine learning model provides high classification accuracy and clinical utility for predicting early hyperkalemia in patients with chronic kidney disease.
Hyperkalemia is a major complication of chronic kidney disease (CKD). However, owing to the absence of specific symptoms in its early stages, hyperkalemia frequently remains undiagnosed. This study aimed to develop a machine learning model for predicting the risk of early hyperkalemia in patients with CKD. By conducting a comparative analysis of six machine learning methods, CatBoost demonstrated superiority across various evaluation metrics. Further evaluation using confusion matrix and decision curve analysis (DCA) confirmed its high classification accuracy and substantial clinical utility. Meanwhile, through multiple interpretability analyses based on SHAP and Local Interpretable Model-agnostic Explanations (LIME) techniques, we precisely quantify the contributions and positive or negative effects of risk factors for hyperkalemia.
Liu et al. (2026) studied this question. The CatBoost model outperformed other machine learning methods in predicting early hyperkalemia risk in patients with chronic kidney disease, demonstrating high classification accuracy.